Evidence map›Paper›PMID 42333440›Full record

ReviewNeurogastroenterology and motility2026

Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease: Interdisciplinary Considerations and Management.

Erin Walsh, Livia Guadagnoli, Julie M Barkmeier-Kraemer, Gregory Dion, Jackie Gartner-Schmidt, Mami Kaneko, Jerome R Lechien, John E Pandolfino, Anne Vertigan, C Prakash Gyawali and 3 more

Abstract readReview
In one paragraph

Review in Neurogastroenterology and motility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Erin WalshDepartment of Otolaryngology, University of California San Diego Health, La Jolla, California, USA.ORCID https://orcid.org/0009-0001-9765-1752
Livia GuadagnoliKenneth C. Griffin Esophageal Center Northwestern Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0002-2925-3955
Julie M Barkmeier-KraemerDepartment of Communication Sciences & Disorders, Department of Otolaryngology-Head & Neck Surgery, University of Utah, Salt Lake City, Utah, USA.
Gregory DionDepartment of Otolaryngology-Head and Neck Surgery, University of Cincinnati, Cincinnati, Ohio, USA.
Jackie Gartner-SchmidtDepartment of Speech-Language Pathology, Carlow University, Pittsburgh, Pennsylvania, USA.
Mami KanekoDepartment of Molecular Cell Physiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Jerome R LechienDepartment of Surgery, University of Mons, Mons, Belgium.ORCID https://orcid.org/0000-0002-0845-0845
John E PandolfinoKenneth C. Griffin Esophageal Center Northwestern Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Anne VertiganSpeech Pathology Department, John Hunter Hospital, Newcastle, Australia.ORCID https://orcid.org/0000-0002-4712-8576
C Prakash GyawaliDivision of Gastroenterology, Washington University School of Medicine, St. Louis, Missouri, USA.
Rena YadlapatiCenter for Esophageal Diseases, University of California San Diego, La Jolla, California, USA.
Justin WuDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
San Diego Consensus Working Group

Funding

Targeting Hypervigilance and Autonomic Arousal: the Psycho-physiologic Model of GERDR01DK092217 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI JOHN E PANDOLFINO · 2012 to 2026
$5.0M
The MVP Trial: A Randomized Controlled Trial of Mechanism Guided vs PPI Strategy for Laryngopharyngeal RefluxR01DK139089 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Rena Hiren Yadlapati · 2024 to 2026
$2.0M
Mechanism Guided Therapy for Laryngopharyngeal RefluxK23DK125266 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YADLAPATI, RENA HIREN · 2021 to 2025
$963k
Role of Psychological Processes on Symptom Burden in Laryngopharyngeal RefluxR03DK135513 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YADLAPATI, RENA HIREN · 2023 to 2024
$245k
NIDDK NIH HHS K23 DK125266NIDDK NIH HHS R01 DK092217NIDDK NIH HHS R01 DK139089NIDDK NIH HHS R03 DK135513NIH HHS K23 DK125266NIH HHS R01 DK092217NIH HHS R01 DK139089NIH HHS R03 DK135513
6 · The paper itself

Abstract

backgroundThe San Diego Consensus for Laryngopharyngeal Symptoms (LPS) and Laryngopharyngeal Reflux Disease (LRPD) describes a broad-based multidisciplinary management paradigm that focuses on mechanisms underlying symptoms to improve treatment outcomes. PURPOSE: This review expands on the San Diego Consensus framework to discuss multidisciplinary management of LPS and LPRD. LPS manifest as persistent or disproportionate symptoms despite minimal or inconsistent evidence of reflux exposure. Emerging evidence suggests that hyperresponsiveness, hypervigilance, and symptom-specific anxiety are more strongly associated with LPS than objective reflux metrics and may contribute to symptom persistence through heightened attention to perceived irritation and protective behavioral responses. Repeated peripheral sensory input may further contribute to central sensitization and lower perceptive thresholds. While these behavioral and neurophysiological processes may be partially improved by reducing reflux exposure, behavioral therapies that address the multidimensional nature of LPS may provide additional benefit. Laryngeal Recalibration Therapy addresses LPS by retraining maladaptive laryngeal behaviors, enhancing vagal tone via heart rate variability biofeedback, and cognitive reframing to reduce symptom amplification. Meta-therapy, a clinical dialogue approach used in speech-language pathology to facilitate behavioral change, alongside psychological interventions such as mindfulness meditation, cognitive-behavioral therapy, and gut-directed hypnotherapy, may further target cognitive-affective processes that shape perception. Behavioral interventions can be combined with neuromodulators, particularly delta ligands such as gabapentin in patients with chronic cough, and tricyclic antidepressants or selective serotonin reuptake inhibitors in select cases. Effective management relies on multidisciplinary collaboration, integration of reflux-directed and behavioral therapies, and patient-centered education that supports adaptive symptom interpretation.

Indexed as

Disease ManagementLaryngopharyngeal RefluxHumanshypervigilancelaryngeal hyperresponsivenesslaryngeal recalibration therapylaryngopharyngeal reflux diseaselaryngopharyngeal symptomssymptom‐specific anxiety

Identifiers

PMID42333440
PMCPMC13601944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.